We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
24 Feb 2021 - 28 Feb 2021
Virtual Venue
03 Mar 2021 - 05 Mar 2021
Virtual Venue

Serum Pentosidine Levels Measured in Systemic Lupus Erythematosus

By LabMedica International staff writers
Posted on 14 Jan 2021
Print article
Image: Photomicrograph of a section of human skin showing a vacuolar interface dermatitis with dermal mucin. These findings are consistent with discoid skin lesions in lupus dermatitis (Photo courtesy of Nephron).
Image: Photomicrograph of a section of human skin showing a vacuolar interface dermatitis with dermal mucin. These findings are consistent with discoid skin lesions in lupus dermatitis (Photo courtesy of Nephron).
Systemic lupus erythematosus (SLE), is the most common type of lupus. SLE is an autoimmune disease in which the immune system attacks its own tissues, causing widespread inflammation and tissue damage in the affected organs. It can affect the joints, skin, brain, lungs, kidneys, and blood vessels.

Inflammation causes oxidative stress and favors protein, lipid and nuclear acids glycation creating products collectively denominated as Advanced Glycation Products (AGEs). Glycation is a non-enzymatic protein modification that occurs in situations of hyper and normal glycaemia being accelerated in the first situation. One of the members of the AGE family is pentosidine that results from the reaction of pentoses with free amino groups such as arginine and lysine.

Medical Scientists at the Mackenzie Evangelical School of Medicine Paraná (Paraná, Brazil) carried out a cross sectional study that included 79 patients that fulfilled at least four of the Classification Criteria for Systemic Lupus Erythematosus (SLE) from Systemic Lupus International Collaborating Clinics (SLICC). Five mL of venous blood was obtained from peripheral vein, aliquoted and stored to −80 °C until pentosidine was measured. At the time of blood collection, ESR (erythrocyte sedimentation rate, C reactive protein (CRP), disease activity by the Safety of Estrogen in Lupus National Assessment Systemic Lupus Erythematosus Disease Activity Index (SELENA-SLEDAI) and cumulative damage were measured. Serum pentosidine levels were measured by commercial ELISA kits (XpressBio, Frederick, MD, USA).

The team reported that that there was no evidence that age, gender and ethnic background impact serum pentosidine levels although lower levels of serum pentosidine were seen in older individuals. Levels of pentosidine did not correlate with patients’ ESR and CRP levels, proteinuria, C3 levels. They also did not observe change in pentosidine levels if the patient had active nephritis at time of blood collection or not. Patients with discoid skin lesions and photosensitivity had lower levels than those without them. In the 79 studied patients, the SLEDAI ranged from 0 to 12 (median of 0) and the SLICC/ACR-DI from 0 to 4 (median of 0). Serum pentosidine levels did not correlate with SLEDAI neither with SLICC.

The authors noted that SLE is a disease where inflammation biomarkers are difficult to interpret. C reactive protein, one of the most commonly used inflammatory indicators is usually low in active lupus and one of the given explanations is that patients with this disease can develop autoantibodies against it. A similar process could have happened with pentosidine. The authors concluded that pentosidine levels did not correlate with disease activity or cumulative damage in lupus. Further studies are needed to understand the role of this biomarker in skin manifestations of SLE. The study was published in the January, 2021 issue of the journal Practical Laboratory Medicine.

Related Links:
Mackenzie Evangelical School of Medicine Paraná

Print article


Molecular Diagnostics

view channel
Image: FIT (Fecal Immunochemical Test) is a stool test designed to identify possible signs of bowel disease. It detects minute amounts of blood in feces (fecal occult blood) (Photo courtesy of Alpha Laboratories, United Kingdom)

Study Confirms Performance of Rapid Stool Test for Detection of Colorectal Cancer

A recently published paper confirmed the diagnostic performance of the fecal immunochemical test (FIT) for patients with low-risk symptoms of colorectal cancer. The FIT uses specific antibodies to detect... Read more


view channel
Image: The Leica Bond III stainer is fully automated Immunohistochemical and In Situ Hybridization (IHC and ISH stainer) (Photo courtesy of Leica Biosystems).

Mismatch Repair/Microsatellite Instability Evaluated Using Cytology Effusion Specimens

DNA mismatch repair (MMR) status is routinely assessed in colorectal and endometrial carcinoma as a method of cancer prevention, surveillance in patients with Lynch syndrome and their families, and for... Read more


view channel

Roche Renews Partnership with Sysmex to Deliver Hematology Testing Solutions

Under the new framework of a Global Business Partnership Agreement (GBP) signed between Roche (Basel, Switzerland) and Sysmex Corporation (Kobe, Japan), both the companies have renewed their commitment... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.